To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects

Phase 1Active Not RecruitingNCT07036458

JW Pharmaceutical8 enrolled

Overview

The following blood, urine and faecal samples will be collected, and assessments performed, at specified time points

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

Subjects will receive a single administration of 14C Epaminurad Oral Solution

Sex: MALEMin age: 30 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1\. Healthy volunteers Exclusion Criteria: 1\. Subjects does not meet the Inclusion Criteria

Quotient Science

Nottingham, United Kingdom

Mass balance recovery of total radioactivity in all excreta (urine and faeces)

Collection of plasma, urine and faeces samples during time frame point

Time frame: Baseline to Day 8

Metabolite profling and structural identification

Collection of plasma, urine and faeces samples during time frame point

Time frame: Baseline to Day 8

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.